Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Sanaria's PfSPZ-CVac Vaccine Achieves High Level Protection Against Malaria in Clinical Trial
Thursday, February 16, 2017In a report published today in Nature Sterile protection against human malaria by chemoattenuated PfSPZ vaccine investigators from the University of Tbingen reported all nine subjects immunized with three doses of Sanaria PfSPZCVac malaria vaccine i...
Pharmapack Europe 2017 highlights new developments in pharma packaging and drug delivery
Thursday, February 16, 2017Pharmapack Europe organised by UBM EMEA closed its edition celebrating its years as the leading European event for pharmaceutical packaging and drug delivery devices The top trends that emerged from the twoday event included patient centricity tr...
Clintec marks 20th year of global clinical research with launch of new brand
Thursday, February 16, 2017Clintec today announces the launch of its new brand identity reflected in their newly created website This in part marks Clintecs th anniversary and the achievement of significant milestones following another year of substantial growth together with...
Theratechnologies Announces New Data from the Pivotal Phase III Trial of HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab
Wednesday, February 15, 2017Theratechnologies Inc Theratechnologies TSX TH announced today that additional secondary efficacy and safety endpoint results from the week ibalizumab Phase III trial TMB were presented at a latebreaker session at the Conference on Retroviruses and O...
Chi-Med and AstraZeneca Present Savolitinib Papillary Renal Cell Carcinoma Phase II Results at 2017 Genitourinary Cancers Symposium
Wednesday, February 15, 2017Hutchison China MediTech Limited ChiMed AIMNasdaq HCM and AstraZeneca PLC AstraZeneca will present data from the ongoing Phase II clinical trial of savolitinib in patients with papillary renal cell carcinoma PRCC at the Genitourinary Cancers Symposi...
MabVax Therapeutics Studies Lead Investigational Drug MVT-5873 with Halozyme PEGPH20
Tuesday, February 14, 2017MabVax Therapeutics Holdings Inc a clinical stage immunooncology drug development company today announced results from a preclinical study evaluating the potential benefits of using MabVaxs HuMabBantibody MVT currently in Phase I clinical trials for...
Armetheon announces issuance of a new U.S. patent for its Phase 2 clinical stage novel oral anti-arrhythmic budiodarone
Tuesday, February 14, 2017Armetheon Inc a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases today announced the issuance on January by the US Patent and Trademark Office USPTO of a new patent covering the companys novel oral...
Under the patronage of H. H. Sheikh Hamdan bin Rashid al Maktoum Award for Medical Sciences, 4TS International Conference 2017
Monday, February 13, 2017Under the patronage of HH Sheikh Hamdan bin Rashid al Maktoum Award for Medical Sciences TS International Conference will take place on thFebruary at Conrad Hotel Dubai The TS International Conference is being organized in collaboration with the Int...
Provectus Biopharmaceuticals, Inc. Announces Extension of Rights Offering
Friday, February 10, 2017Provectus Biopharmaceuticals Inc a clinicalstage oncology and dermatology biopharmaceutical company today announced that it has extended the expiration date of its rights offering to Friday March at pm Eastern Time All other terms and conditions o...
Newfound Effect of Cancer Drug May Expand its Use
Friday, February 10, 2017A drug first designed to prevent cancer cells from multiplying has a second effect it switches immune cells that turn down the bodys attack on tumors back into the kind that amplify it This is the finding of a study led by researchers from NYU Langon...
